Επιστημονικές δημοσιεύσεις
11/2024: Non-alcoholic Wernicke Encephalopathy in a Young Patient with Adenocarcinoma of the Colon: A Case Report and Review of the Literature
9/2024: Combining immunotherapy with PARP inhibitors. Is it possible to find the way through?
3/2024: Going with the flow while thinking outside the box: Case report of a primary extrapelvic clear cell endometrial carcinoma associated with cesarean scar endometriosis (forthcoming)
2/2024: Acute phantosmia as the first manifestation of brain metastases in a patient with breast cancer. Case report (in press)
12/2023: PARP inhibitors in colorectal malignancies: a 2023 update
10/2023: Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations
3/2023: Is the patient actually failing on enzalutamide? A case report and issues to consider in enzalutamide-resistant oligoprogressive castrate-resistant prostate cancer
3/2023: Immune checkpoint inhibitors and combinations with other agents in cholangiocarcinoma
8/2022: Can thromboprophylaxis build a link for cancer patients undergoing surgical and / or chemotherapy treatment? The METHOS cohort study
2/2022: Systemic treatment of Ewing Sarcoma: Current Options and Future Perspectives
1/2022: Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
12/2021: Case report: Combination of Olaparib with Chemotherapy in a patient with ATM-deficient colorectal cancer
10/2021: Case Report: Adenocarcinoma of the larynx with later hepatocellular differentiation
8/2021: Perforated appendicitis induced by pembrolizumab – A case report and review of the literature
8/2021: An overview of current results with the Vincristine-Irinotecan-Temozolomide combination with or without Bevacizumab in pediatric, adolescense and adult solid tumors
7/2021: Central neurotoxicity induced by trastuzumab emtansine (T-DM1)-a case report
7/2021: High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy
6/2021: Immunotherapy for cholangiocarcinoma: a 2021 update
1/2021: Notable response of a young adult with recurrent glioblastoma multiforme to vincristine – irinotecan – temozolomide and bevacizumab
9/2020: Can thromboprophylaxis build a link for cancer patients undergoing surgical and / or chemotherapy treatment? Intermediate results from the METHOS study
1/2020: CNS Tumors in Adolescents and Young Adults: The Need for a Holistic Specialized Approach